๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

JNK1, a potential therapeutic target for hepatocellular carcinoma

โœ Scribed by Fei Chen; Kevin Beezhold; Vince Castranova

Book ID
113486717
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
408 KB
Volume
1796
Category
Article
ISSN
0304-419X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

c-Met represents a potential therapeutic
c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma
โœ Hanning You; Wei Ding; Hien Dang; Yixing Jiang; C. Bart Rountree ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 943 KB

c-Met, a high-affinity receptor for hepatocyte growth factor (HGF), plays a critical role in cancer growth, invasion, and metastasis. Hepatocellular carcinoma (HCC) patients with an active HGF/c-Met signaling pathway have a significantly worse prognosis. Although targeting the HGF/c-Met pathway has

JNK: a new therapeutic target for diabet
JNK: a new therapeutic target for diabetes
โœ Brydon L Bennett; Yoshitaka Satoh; Alan J Lewis ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 219 KB
Granulin-epithelin precursor as a therap
Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma
โœ Jenny C. Ho; Ying Chi Ip; Siu Tim Cheung; Yuk Ting Lee; Kui Fat Chan; San Yu Won ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 823 KB

Primary liver cancer, hepatocellular carcinoma (HCC), is the fifth most common cancer and the third leading cancer killer in the world. There is no effective therapeutic option for most HCC patients. A new therapeutic strategy is essential. Granulin-epithelin precursor (GEP, also called progranulin,